5 takeaways from AP's report on the big backlog of uninspected drug factories
2 years ago
30
ARTICLE AD BOX
Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address a massive backlog of uninspected pharmaceutical plants